| 000 | 01069nam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | vtls000097503 | ||
| 003 | KUKTEM | ||
| 005 | 20251125103409.0 | ||
| 008 | 160906t2015 enka f 001 0 eng d | ||
| 020 | _a9781849739085 (hbk.) | ||
| 039 | 9 |
_a201701041130 _bsaini _y201609061642 _zepul |
|
| 040 | _aUMP | ||
| 090 | _aRM301.25 .F73 2015 | ||
| 245 | 0 | 0 |
_aFragment-based drug discovery / _cedited by Steven Howard, Chris Abell |
| 260 |
_aCambridge : _bThe Royal Society of Chemistry, _c2015 |
||
| 300 |
_axlix, 264 p. : _bill. (some col.) ; _c24 cm. |
||
| 490 | 1 |
_aRSC drug discovery, _x2041-3203 ; _v47 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 | _aDrug development | |
| 650 | 0 | _aLigands (Biochemistry) | |
| 650 | 2 | _aDrug Discovery | |
| 650 | 2 | _aLigands | |
| 700 | 1 | _aHoward, Steven | |
| 700 | 1 | _aAbell, C. | |
| 710 | 2 | _aThe Royal Society of Chemistry (Great Britain) | |
| 830 | 0 |
_aRSC drug discovery ; _v47 |
|
| 999 |
_aVIRTUA40 _c85003 _d85009 |
||
| 999 | _aVTLSSORT0080*0200*0400*0900*2450*2600*3000*4900*5040*6500*6501*6502*6503*7000*7001*7100*8300*9992 | ||